Beryl Capital Management’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-70,236
Closed -$43K – 56
2022
Q1
$43K Buy
+70,236
New +$38.3K ﹤0.01% 253

Other funds holding DRTSW

Beryl Capital Management's DRTSW Position: Q2 2022 in Review

Beryl Capital Management sold out of Alpha Tau Medical Warrant (DRTSW) in Q2 2022, closing a stake of 70,236 shares — an estimated $43K sold.

Beryl Capital Management first reported a position in DRTSW in Q1 2022 and held it in 1 quarter. The position peaked at $43K in Q1 2022. 37 funds tracked by Wall St. Rank hold DRTSW as of Q2 2022.

  • Beryl Capital Management reported no remaining Alpha Tau Medical Warrant position as of Q2 2022 after selling out during the quarter.
  • Beryl Capital Management sold 70,236 Alpha Tau Medical Warrant shares in Q2 2022, an estimated $43K.
  • Beryl Capital Management first reported a position in Alpha Tau Medical Warrant in Q1 2022 and held it in 1 quarter.
  • Beryl Capital Management's Alpha Tau Medical Warrant position peaked at $43K in Q1 2022.
  • 37 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q2 2022.

Based on Beryl Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.